Three-Dimensional Structure of the Complex between a T Cell Receptor β Chain and the Superantigen Staphylococcal Enterotoxin B  by Li, Hongmin et al.
Immunity, Vol. 9, 807±816, December, 1998, Copyright 1998 by Cell Press
Three-Dimensional Structure of the Complex
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leading to the massive release of T cell±derived cyto-
kines such as interleukin-2 and tumor necrosis factor
(Kotzin et al., 1993; Webb and Gascoigne, 1994). Activa-
tion requires simultaneous interaction of the SAG with
the TCR and with MHC class II molecules on an antigen-
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clude the staphylococcal exfoliative toxins (Vath et al.,Postfach CH-4005, Basel
1997), the streptococcal pyrogenic exotoxins (BohachSwitzerland
et al., 1990), Mycoplasma arthritidis mitogen (MAM)
(Cole and Griffiths, 1993), and Yersinia pseudotubercu-
losis-derived mitogen (YPM) (Ito et al., 1995; Miyoshi-Summary
Akiyama et al., 1995). In addition, mouse mammary tu-
mor viruses (MMTVs) encode endogenous SAGs thatSuperantigens (SAGs) are a class of immunostimula-
enable these retroviruses to exploit the host immunetory proteins of bacterial or viral origin that activate T
system for their transmission (Kotzin et al., 1993; Scherercells by binding to the Vb domain of the T cell antigen
et al., 1993).receptor (TCR). The three-dimensional structure of the
It has also been proposed that SAGs derived fromcomplex between a TCR b chain (mouse Vb8.2) and
bacteria, mycoplasma, or viruses may contribute to the
the SAG staphylococcal enterotoxin B (SEB) at 2.4 AÊ
pathogenesis of autoimmune disease by activating T
resolution reveals why SEB recognizes only certain
cells specific for self antigens (Kotzin et al., 1993; Renno
Vb families, as well as why only certain SAGs bind
and Acha-Orbea, 1996). For example, Paliard et al. (1992)
mouse Vb8.2. Models of the TCR-SEB-peptide/MHC
analyzed the TCR b chain repertoire of synovial T cells
class II complex indicate that Va interacts with the from rheumatoid arthritis (RA) patients and found a se-
MHC b chain in the TCR-SAG-MHC complex. The ex- lective expansion of Vb14-bearing T cells compared to
tent of the interaction is variable and is largely deter- the levels in the peripheral blood of the same individuals.
mined by the geometry of Va/Vb domain association. The authors proposed a mechanism for the pathogene-
This variability can account for the preferential ex- sis of RA in which a microbial SAG activates disease-
pression of certain Va regions among T cells reactive mediating Vb141 T cells and allows these activated cells
with SEB. to enter the synovial tissue, where they persist because
of reactivation by autoantigens. Similarly, an analysis
Introduction of pancreatic islet-infiltrating T cells from patients with
insulin-dependent diabetes mellitus (IDDM) revealed
T lymphocytes recognize a wide variety of antigens preferential expression of the Vb7 gene segment but no
through highly diverse cell-surface glycoproteins known selection for particular Va segments or Vb-D-Jb junc-
as T cell receptors (TCRs). These disulfide-linked hetero- tional sequences (Conrad et al., 1994), suggesting that
dimers are comprised of a and b or g and d chains a SAG associated with pancreatic islets may be involved
that have variable (V) and constant (C) regions that are in the pathogenesis. In experimental autoimmune en-
structurally homologous to those of antibodies (Wilson cephalomyelitis (EAE), a model for multiple sclerosis,
and Garcia, 1997; Li et al., 1998). Unlike antibodies, how- administration of stapylococcal enterotoxin B (SEB) to
ever, which recognize antigen alone, ab TCRs recognize mice following immunization with a peptide from myelin
antigen only in the form of peptides bound to MHC basic protein (MPB Ac1-11) was found to trigger re-
molecules. In addition, TCRs interact with glycolipids lapses in mice that were in remission following an initial
presented by CD1 and with a class of viral or bacterial episode of paralysis (Brocke et al., 1993; Racke et al.,
proteins known as superantigens (SAGs). Microbial 1994). It was shown that this effect is the direct result
SAGs stimulate T cells bearing particular Vb elements, of stimulation by SEB of Vb8-expressing encephalito-
genic T cells specific for MBP Ac1-11.
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14.3.d) specific for a hemagglutinin peptide of influenza unless otherwise stated, the major conclusions apply
equally well to both complexes.virus bound to I-Ed (Fields et al., 1996). This structure
identified the regions of the b chain recognized by SEC3 The overall structure of the b-SEB complex is shown
in Figure 2A. The complex is formed through contactsand showed how SAGs circumvent the normal mecha-
nism for T cell activation by specific peptide/MHC com- between the Vb domain and the small and large domains
of SEB. The complementarity-determining region 2plexes. However, the moderate resolution of the b-SEC3
complex (3.5 AÊ ) precluded a detailed analysis of the (CDR2) of the TCR b chain and, to lesser extents, hyper-
variable region 4 (HV4) and framework regions 2 and 3interface between the two proteins in terms of hydrogen
bonds, van der Waals interactions, and solvent struc- (FR2 and FR3), bind in the cleft between the two domains
of the SAG. This binding mode is nearly the same asture. In order to achieve a more complete description
of a b-SAG interface, as well as to determine whether previously observed in the crystal structure of the TCR
b-SEC3 complex (Fields et al., 1996), but with severalconformational changes occur in either or both proteins
upon complex formation, we have now determined the important differences, as discussed below. The solvent-
excluded surface area for the b-SEB complex is 1343crystal structure of the complex between the 14.3.d b
chain and SEB to 2.4 AÊ resolution. This structure, along AÊ 2 (685 AÊ 2 from Vb and 658 AÊ 2 from SEB), which is within
the range observed for antigen-antibody complexes in-with those of ab TCR heterodimers (Garcia et al., 1996;
Housset et al., 1997; Wang et al., 1998) and TCR-pep- volving protein antigens (Padlan, 1994) but somewhat
smaller than the approximately 1800 AÊ 2 of buried surfacetide/MHC complexes (Garboczi et al., 1996; Ding et al.,
1998; Garcia et al., 1998), allows us to explain the struc- in TCR-peptide/MHC complexes (Garboczi et al., 1996;
Garcia et al., 1998). As shown in Figure 2A, the TCR-tural basis for the specificity of different SAGs for partic-
ular b chains and for the observed influence of the TCR binding site of SEB is adjacent to, but distinct from, the
MHC-binding site of this SAG (Jardetzky et al., 1994).a chain on SAG reactivity (Deckhut et al., 1994; La-
brecque et al., 1994; Blackman and Woodland, 1996). Because the asymmetric unit of the b-SEB crystal
contains two molecules of the complex (designated
b-SEB1 and b-SEB2) in very different crystallographicResults and Discussion
environments, we can infer characteristics about the
intrinsic flexibility, versus rigidity, of TCR-SAG associa-Overall Structure of the TCR b Chain-SEB Complex
We determined the structure of the 14.3.d TCR VbCb tion. The r.m.s. differences between b-SEB1 and b-SEB2
are only 0.18 AÊ , 0.24 AÊ , and 0.21 AÊ for Vb, Cb, and SEB,chain complexed with wild-type SEB to 2.4 AÊ resolution
by the molecular replacement method using the 14.3.d respectively. However, when b-SEB1 is overlaid onto
b-SEB2 by superposing their Vb domains, it is apparentb chain (Bentley et al., 1995) and SEB (Swaminathan et
al., 1992) as search models. We also determined the that the relative orientations of both Cb and SEB are
different, such that the two complexes, although verystructure, to 2.6 AÊ resolution, of the complex between
the 14.3.d b chain and a mutant of SEB in which valine similar, are not identical (Figure 2B). A rotational differ-
ence of 118 occurs in the orientation of the Cb domainat position 26 is replaced by tyrosine (SEB V26Y). This
mutant was designed on the basis of the structure of of b-SEB1 relative to that in b-SEB2. However, both
Vb-Cb orientations are within the rather narrow (com-the TCR b-SEC3 complex (Fields et al., 1996) to bind
the b chain more tightly than wild-type SEB: its KD is 12 pared with antibody VH-CH1 orientations) range reported
for ab TCR heterodimers (Garcia et al., 1996; Wang etmM, approximately 12 times lower than that of SEB (KD 5
140 mM) but still four times higher than that of SEC3 al., 1998). Thus, there is no evidence that the observed
difference in Vb-Cb orientation is the result of engage-(KD 5 3 mM) (Leder et al., 1998). The SEB V26Y mutant
is about 4-fold more active in T cell proliferation assays ment of the TCR by the SAG. A similar conclusion has
been reached for TCR-peptide/MHC complexes (Gar-than the wild-type toxin, consistent with its enhanced
affinity. The crystallographic data and structure refine- boczi et al., 1996; Ding et al., 1998; Garcia et al., 1998).
With respect to the SAG, a rotation of 68 is requiredment statistics for the b-SEB and b-SEB V26Y com-
plexes are summarized in Table 1. Crystals of the mutant to optimize the overlap between SEB molecules in the
b-SEB1 and b-SEB2 complexes following superpositioncomplex are isomorphous with those of the wild-type,
with two molecules of the b-SAG complex per asymmet- of their Vb domains. This difference is essentially a rota-
tion of the SEB molecule around the CDR2 loop of theric unit. All of the domains of both complexes in the
asymmetric unit are ordered in the b-SEB and b-SEB Vb domain. The consequence of the rotation is that,
although the same set of hydrogen bonds is maintainedV26Y structures, with only several loops in Cb and the
SAG lacking electron density (see Experimental Proce- in the two complexes (Table 2A), differences are ob-
served in the number of van der Waals contacts madedures). The Vb domain appears to be the most ordered,
as reflected by lower mean temperature (B) factors than at most interface positions (data not shown). For exam-
ple, Vb His47 makes four van der Waals contacts withfor Cb and the SAG (Table 1); in addition, there is no
missing electron density for any Vb residues. The inter- SEB Phe177 in the b-SEB1 complex but only two with
this residue in b-SEB2, whereas Vb Lys57 makes noface between the TCR b chain and the SAG is in unam-
biguous electron density for both the wild-type and mu- contacts with SEB Gly19 in b-SEB1 but three in b-SEB2.
Thus, small yet significant differences in TCR-SAG orien-tant complexes (Figures 1A and 1B, respectively); the
mutation from valine to tyrosine at SEB position 26 is tation may exist even when the interacting proteins are
chemically identical in two complexes. A similar obser-clearly visible. Superposition of the b-SEB and b-SEB
V26Y complexes gives a root-mean-square (r.m.s.) dif- vation was recently made by Wang et al. (1998) in the
case of an Fab-TCR complex that also crystallizes withference of only 0.47 AÊ for all a-carbon atoms. Therefore,
Crystal Structure of TCR b Chain-SEB Complex
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Table 1. Crystal Structure Determination of TCRb-SEB and TCRb-SEB V26Y Complexes
Data Collection
Cell parameters b-SEB b-SEB V26Y
a (AÊ ) 71.20 70.89
b (AÊ ) 83.65 83.07
c (AÊ ) 82.98 82.76
b (8) 93.04 92.83
Mosaicity (8) 1.6 1.3
Resolution (AÊ ) 2.4 2.6
Observations 325939 291259
Unique reflections 34943 28757
Completeness (%) 91.5 (79.1)a 97.0 (90.6)a
Mean I/s(I) 19.4 (4.1)a 25.3 (6.1)a
Rsym (%)b 9.2 8.1
Refinement
Resolution range (AÊ ) 6±2.4 6±2.6
Rwork (%)b 22.8 22.9
Rfree (%)b 30.9 32.6
Non-hydrogen protein atoms 7589 7553
Water molecules 179 31
r.m.s. deviations from ideality
Bond lengths (AÊ ) 0.006 0.008
Bond angles (8) 1.791 1.370
Mean B factors (AÊ 2) b-SEB1 b-SEB2 b-SEBm1 b-SEBm2
Vb 23.5 27.6 29.0 34.7
Cb 40.6 41.8 59.4 53.4
SEB (SEB V26Y) 37.1 38.2 51.7 57.0
Water molecules 40.7 47.0
a Values in parentheses correspond to the highest resolution shell.
b Rsym 5 S|(Ihkl2I,hkl.)|/S(I,hkl.), where I,hkl. is the mean intensity of all reflections equivalent to reflection hkl by symmetry; Rwork(Rfree) 5 S||Fo|2|Fc||/
S|Fo|; numbers of reflections used for Rfree are 2647 and 1839 for the b-SEB and b-SEB V26Y complexes, respectively. b-SEB1 and b-SEB2
refer to the two complex molecules in the asymmetric unit of the b-SEB crystal; b-SEBm1 and b-SEBm2 refer to the two complex molecules
in the asymmetric unit of the b-SEB V26Y mutant crystal.
two complex molecules per asymmetric unit: superpo- CDR2 and FR3 account for the large majority of interac-
tions with the SAG in both cases (84% in b-SEB andsition of the TCRs revealed a rotational difference of 188
in the position of the Fabs. These results suggest a 94% in b-SEC3), with HV4 playing only a secondary
role. The binding sites on the TCR b chain for SAG andlimited degree of structural flexibility in both antigen-
antibody and TCR-SAG association. That is, b-SEB1 peptide/MHC class I only partially overlap. As shown in
Table 2, only Vb CDR2 residues Tyr50, Ala52, and Thr55,and b-SEB2 could represent two slightly different forms
of the b-SAG complex that exist in equilibrium in solu- and FR3 residue Glu56, contact both SEB and peptide/
MHC in the 2C TCR-dEV8/H-2Kb complex (Garcia et al.,tion. Alternatively, crystal packing could distort one or
the other complex. For simplicity, all subsequent discus- 1998). The SEB residues in contact with Vb are Asn60,
Tyr90, and Tyr91 of the small domain and Thr18, Gly19,sion is based on one of the two b-SEB molecules in the
asymmetric unit (b-SEB1), unless otherwise noted. Leu20, Glu22, Asn23, Tyr26 (in the b-SEB V26Y complex
only), Phe177, and Glu210 of the large domain (Table
2). Residues Asn23, Asn60, and Tyr90 are strictly con-Structure of the TCR b Chain-SEB Interface
served among bacterial SAGs reactive with mouseThe Vb residues in contact with SEB are His47 of FR2;
Vb8.2, including SEC1-3 and streptococcal pyrogenicTyr50, Ala52, Gly53, Ser54 and Thr55 of CDR2; Glu56,
exotoxin A (SPEA), and have been shown to constituteLys57, Tyr65, Lys66, and Ala67 of FR3; and Pro70 and
energetic ªhot spotsº for binding the 14.3.d b chainSer71 of HV4 (Table 2). The FR2, CDR2, FR3, and HV4
(Leder et al., 1998).regions account for 7, 50, 34, and 9%, respectively, of
Application of the algorithim of Lawrence and Colmanthe total contacts to the SAG. In the b-SEC3 complex
(1993) for quantitating shape complementarity in pro-(Fields et al., 1996), the Vb residues in contact with
tein-protein interfaces to the b-SEB complex gives aSEC3 are Tyr50, Gly51, Ala52, Gly53, Ser54, and Thr55
shape correlation statistic (Sc) of 0.63 (Sc 5 1 for inter-of CDR2; Glu56, Lys57 and Lys66 of FR3; and Pro70
faces with perfect fits). Since antigen-antibody com-and Ser71 of HV4 (Table 2). The CDR2, FR3, and HV4
plexes have Sc values of 0.64-0.68 (Lawrence andregions account for 63, 32, and 7%, respectively, of the
Colman, 1993) and TCR-peptide/MHC complexes oftotal contacts to SEC3. Thus, although there are two
0.45-0.47 (Garcia et al., 1998), the b-SEB interface isdifferences in contacting residues in the two complexes
about as tightly packed as antigen-antibody interfaces(Vb FR2 His47, which contacts SEB but not SEC3, and
Vb CDR2 Gly51, which contacts SEC3 but not SEB), but significantly more tightly packed than TCR-peptide/
Immunity
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Figure 1. TCR b-SEB Interface
(A) Electron density from the final 2.4 AÊ
sA-weighted 2Fo-Fc map of the wild-type TCR
b-SEB complex, contoured at 1s, in the re-
gion of the interface.
(B) Electron density from the final 2.6 AÊ simu-
lated annealing map of the mutant TCR
b-SEB V26Y complex, contoured at 1s, show-
ing the Val26→Tyr substitution in SEB; the
view is the same as in (A). SEB residues are
indicated with an asterisk. Bound water mole-
cules are drawn as pink spheres. Carbon, ni-
trogen, and oxygen atoms are colored yellow,
blue, and red, respectively. All figures were
generated by Molscript (Kraulis, 1991) and
Raster 3D (Bacon and Anderson, 1988; Mer-
ritt and Bacon, 1997) if not specified.
(C) Interactions in the wild-type b-SEB inter-
face. Vb atoms are colored according to atom
type as in (A); SEB is colored green. Pink
spheres represent interface water molecules.
(D) Interactions in the mutant b-SEB V26Y
interface. SEB V26Y is colored blue. Hydro-
gen bonds are dotted brown lines. SAG resi-
dues are indicated with asterisks.
MHC interfaces. This suggests that the SAG has evolved chain oxygen of SEB Thr18 and the side chain of Vb
Lys57 (SEB Thr18 O-Nz Lys57 Vb). Four of the interfaceto optimize its fit to the TCR.
The b-SEB and b-SEB V26Y interfaces are shown in hydrogen bonds in the b-SEB and b-SEB V26Y com-
plexes are also present in the b-SEC3 complex: Vb Gly53detail in Figures 1C and 1D, respectively. All the hydro-
gen bonds between SEB and Vb are formed between O-Ne2 Gln210 SEB, Vb Thr55 N-Od1 Asn23 SEB, Vb
Thr55 O-Nd2 Asn23 SEB, and Vb Pro70 O-Nd2 Asn60SEB side chain atoms and Vb main chain atoms, as
previously described for the b-SEC3 complex (Fields et SEB (Table 2A). The importance of these conserved
interactions for complex stabilization is demonstratedal., 1996), except for a hydrogen bond between the main
Figure 2. TCR b-SEB Complex
(A) Ribbons diagram of the VbCb-SEB com-
plex. Colors are as follows: Vb (yellow),
CDR1 (pink), CDR2 (red), CDR3 (purple), HV4
(green), Cb (orange), SEB large domain (gray),
and SEB small domain (blue). Residues of Vb
and SEB involved in interactions in the TCR-
SAG interface are red. Residues of SEB in
contact with MHC in the structure of the SEB-
HLA-DR1 complex (Jardetzky et al., 1994) are
yellow. The SEB disulfide loop (light gray) was
modeled according to the uncomplexed SEB
crystal structure.
(B) Superposition of the two VbCb-SEB com-
plex molecules (b-SEB1 and b-SEB2) in the
asymmetric unit. The a-carbon diagram of
b-SEB1 is red and that of b-SEB2 is green.
The complexes were overlaid by superposing
their Vb domains. The view is the same as in
(A). Figure was drawn using TURBO-FRODO
(Roussell and Cambillau, 1989).
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domain in the VbCb-SEB structure, residue Leu98 of A6Table 2. Contacts between the 14.3 d TCR b Chain and
Vb CDR3, located at the tip of this long protruding loop,Staphylococcal Superantigens
is predicted to contact SEB residue Tyr94 (data not
A. Hydrogen Bonds
shown). Similar interactions may explain the observed
b SEB SEBV26Y SEC3 influence of Vb CDR3 residues on T cell reactivity toward
MAM (Hodtsev et al., 1998) and mouse retroviral Mtv-9G53 O Q210 Ne2 Q210 Ne2 Q210 Ne2
SAG (Ciurli et al., 1998). Alternatively, these other SAGsT55³ N N23 Od1 N23 Od1 N23 Od1
O Nd2 Nd2 Nd2 may bind the TCR differently than SEB.
O T20 Og1
K57 Nzb T18 O T18 O Conformational Changes in the Interface
P70 Oa N60 Nd2 N60 Nd2 N60 Nd2
between the TCR b Chain and SEB
B. Van der Waals Contacts² The availability of high resolution crystal structures for
uncomplexed 14.3.d b chain (Bentley et al., 1995) andb SEB SEBV26Y SEC3
SEB (Swaminathan et al., 1992) allows us to assess
H47 L20 L20
whether any conformational changes occur in Vb or theF177 F177
SAG upon complex formation. The free and complexedY50³ Y91 Y91 V91
Vb domains superpose with a r.m.s. difference of 0.33G51 V91
A52³ Y90 Y90 Y90 AÊ for all 114 a-carbon atoms. Similarly, the unbound
Y91 and bound SEB molecules superpose with a r.m.s. dif-
G53 N23 N23 N23 ference of 0.54 AÊ for all 239 a-carbons. Thus, there are
Y26 Y26
no major rearrangements in the polypeptide backbonesQ210 Q210 Q210
of Vb or SEB associated with complex formation (FigureS54 N23 N23 N23
3A), as previously noted for the b-SEC3 complex (FieldsV91
T55³ L20 L20 T20 et al., 1996). However, a number of small adjustments
N23 N23 N23 in Vb and SAG side chain positions are evident by com-
E22 E22 paring the free and bound structures of the 14.3.d b
F177 F177
chain and SEB (Figure 3B). Certain of these changesE56³ L20 L20 T20
are necessary to avoid steric clashes between TCR andN23
SAG, while others probably serve to maximize produc-K57 T18 T18
G19 G19 G19 tive interactions between the two proteins. For example,
L20 L20 T20 the phenyl ring of Vb Tyr50 rotates 208 towards the SEB
Y65 F177 F177 molecule, while the side chain of Vb Lys57 shifts 178
K66 F177 F177 F176
away from the SAG. The Vb CDR2 loop (residues 49±55)A67 F177 F177 F176
appears to be slightly pushed down by SEB, with aP70 N60 N60
maximum displacement of 1.0 AÊ in the position of theL58 L58
S71 N60 N60 N60 Ser54 a-carbon atom. The most significant conforma-
tional change in SEB occurs at residue Tyr91, whose³ Vb residues in contact with peptide/MHC in the 2C TCR-dEV8/H-
side chain position differs from that of the uncomplexed2Kb complex (Garcia et al., 1998); a refers to the first complex mole-
cule in the asymmetric unit; b refers to the second complex; ² Van structure (Swaminathan et al., 1992) by a rotation of
der Waals contacts ,4.0AÊ ; Data for the b-SEC3 complex are from 1208, which is required to avoid steric clashes with Vb
Fields et al. (1996). CDR2. These structural rearrangements are of similar
magnitude to those observed in antigen-antibody com-
plexes in which the antigen is a protein (Davies and
by the finding that SEC3 mutants Asn23→Ala and Padlan, 1992; Tulip et al., 1992; Bhat et al., 1994; Fields
Gln210→Ala bind the TCR b chain .70-fold less tightly et al., 1995) but smaller than those for certain complexes
than the wild-type SAG, while SEC3 Asn60→Ala binds involving DNA or peptide antigens (Wilson and Stanfield,
16-fold less tightly (Leder et al., 1998). Four water mole- 1993). The observation that the two b-SEB molecules
cules were found to form hydrogen bonds bridging Vb in the asymmetric unit of the crystal differ somewhat in
and SEB. Bound waters have also been observed in the their Vb-SEB orientations (Figure 2B; see above) pro-
combining site of antibodies, where they act to increase vides additional evidence for a certain degree of struc-
complementarity in the interface with antigen (Bhat et tural flexibility at the TCR-SAG interface.
al., 1994; Fields et al., 1995; Dall'Acqua et al., 1998). The changes in the conformation of interface residues
There are no direct contacts between SEB and Vb in the 14.3.d b-SEB complex are not as large as those
CDR3, which folds away from the SAG (Figure 2A; Table in the 2C TCR-dEV8/H-2Kb complex, in which the CDR1
2); this is consistent with the finding that bacterial and and CDR3 loops of the Va domain are displaced 4±6 AÊ
viral SAGs stimulate T cells expressing particular Vb relative to their positions in the unliganded 2C TCR
elements without obvious selection for Vb CDR3 length structure (Garcia et al., 1998). For both complexes, how-
or sequence (Kotzin et al., 1993; Scherer et al., 1993; ever, the observed conformational changes are local-
Webb and Gascoigne, 1994). However, this does not ized to the interface between the proteins and are not
rule out the possibility that, depending on its conforma- transmitted to the constant regions of the TCR; there-
tion, Vb CDR3 may in certain cases modulate SAG reac- fore, changes in TCR structure upon ligand binding are
tivity. For example, when the Vb domain of TCR A6 unlikely to account for signal transduction across the T
cell membrane.(Garboczi et al., 1996) is superposed onto the 14.3.d Vb
Immunity
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Figure 3. Conformational Differences between
Complexed and Uncomplexed Vb Chain and
SEB
(A) In the 14.3.d TCR b-SEB structure, uncom-
plexed Vb (green) was superposed onto com-
plexed Vb (red), and uncomplexed SEB (yel-
low) was superposed onto complexed SEB
(blue). Only a-carbon atoms are shown.
(B) Closeup of the b-SEB interface. Bound
and unbound Vb and SEB are colored as in
(A); Vb and SEB residues are labeled in black
and blue, respectively.
Structural Basis for the Vb-Binding Specificity have been described with reactivity toward members of
the mouse Vb2 family (Kotzin et al., 1993), consistentof Bacterial SAGs
The structure of the 14.3.d b chain-SEB complex allows with the unique folding topology of Vb2.3. Similarly,
when mouse Vb5.2 (Wang et al., 1998) is superposedus to explain why SEB recognizes certain Vb families
but not others. As discussed above, all the hydrogen onto mouse Vb8.2 (Figure 4C), the r.m.s difference in
a-carbon positions for 14 residues in the SEB-bindingbonds between SEB and mouse Vb8.2 are formed be-
tween SEB side chains and Vb backbone atoms (Figure site is 2.1 AÊ . This difference is mostly attributable to a
displacement of the c99 strand in a direction opposite1C), such that the positions of these backbone atoms
should be very similar in Vb domains reactive with SEB from that of the c99 strand in the mouse Vb2.3 domain,
which again results in a repositioning of CDR2 and FR3.but significantly different in Vbs that do not bind this
SAG. A comparison of Vb domains of known three- Except for MAM, which reacts with mouse Vb5.1, no
SAGs specific for members of the mouse Vb5 familydimensional structure confirms this prediction. Thus,
SEB activates T cells bearing mouse Vb8 and human have been reported (Kotzin et al., 1993). These results
indicate that the relative position of the c99 strand in VbVb12 but not mouse Vb2 or Vb5 (Kotzin et al., 1993).
When human Vb12.3 (Garboczi et al., 1996) is super- domains is critical in determining their reactivity toward
different microbial SAGs and suggest that Vbs reactiveposed onto mouse Vb8.2 (Figure 4A), the r.m.s. differ-
ence in a-carbon positions for 14 residues in the SEB- with SEB or SEC (mouse Vb3, 7, 10, 11, and 17; human
Vb3, 5, 12, 13, 14, 15, 17, and 20) probably have a verybinding site is only 0.9 AÊ . However, when mouse Vb2.3
(Housset et al., 1997) is superposed onto mouse Vb8.2 similar b-strand topology in their SAG-binding sites as
mouse Vb8.2.(Figure 4B), the r.m.s. difference is 3.0 AÊ . This difference
is mainly attributable to a strand switch in Vb2.3 relative The structure of the 14.3.d b chain-SEB complex also
enables us to understand why T cells expressing mouseto other Vb domains of known structure: in Vb2.3 the
c99 strand (which corresponds to the part of FR3 in con- Vb8.2 are stimulated by SEC1-3 and SPEA but not by
SEA, SED, SEE, TSST-1, or SPEC (Imanishi et al., 1990;tact with SEB) is hydrogen bonded to the d strand of
the adjacent (outer) b sheet, whereas in other Vbs the Kotzin et al., 1993). When SEC3 (Hoffmann et al., 1994)
is superposed onto SEB (Swaminathan et al., 1992), thec99 strand is associated with the c9 strand in the same
(inner) sheet (Bentley et al., 1995; Garboczi et al., 1996; r.m.s. difference in a-carbon positions for 11 residues in
the TCR-binding site is only 0.51 AÊ . Indeed, as discussedGarcia et al., 1996; Wang et al., 1998). A consequence
of the c99 strand switch is a repositioning of CDR2 and above, SEC2 and 3 bind the 14.3.d b chain in a very
similar orientation as SEB. Although the three-dimen-FR3, regions that contribute 50% and 34%, respectively,
of the total contacts to SEB in the b-SEB complex. It sional structure of SPEA is not known, a sequence align-
ment with SEB and SEC reveals that it retains severalshould also be noted that no bacterial or viral SAGs
Figure 4. Comparison of Vb Structures in the
Region of the SEB-Binding Site
(A) Mouse Vb8.2 (yellow) (Bentley et al., 1995)
superposed onto human Vb12.3 (blue) (Gar-
boczi et al., 1996). The CDR loops are num-
bered 1, 2, and 3; HV4 is labeled 4. (B) Mouse
Vb8.2 (yellow) superposed onto mouse Vb2.3
(red) (Housset et al., 1997). (C) Mouse Vb8.2
(yellow) superposed onto mouse Vb5.2 (green)
(Wang et al., 1998). The SEB-binding site of
mouse Vb8.2 is circled in each panel.
Crystal Structure of TCR b Chain-SEB Complex
813
Figure 5. Comparison of TCR-SAG-Peptide/
MHC and TCR-Peptide/MHC Complexes
(A) Model of the TCR-SEB-peptide/MHC class
II complex constructed by least-squares su-
perposition of (1) the 14.3.d VbCb-SEB com-
plex, (2) the SEB-peptide/HLA-DR1 complex
(Jardetzky et al., 1994), and (3) the 2C TCR
ab heterodimer (Garcia et al., 1996).
(B) Structure of the 2C TCR-peptide/MHC
class I complex (Garcia et al., 1998). The com-
plex is oriented such that the MHC molecule
is approximately aligned with that in (A).
(C) Another view of the 2C TCR-peptide/MHC
class I complex. The complex is oriented
such that the TCRs in (A) and (C) are aligned.
key Vb-contacting residues, in particular Asn60, Tyr90, site. By contrast, in our model of the TCR-SEB-peptide/
MHC complex (Figure 5A), the peptide is effectively re-and Gln210 (Leder et al., 1998). Alanine-scanning muta-
genesis has shown that these three residues are hot moved from the TCR combining site and there are no
direct contacts between the TCR b chain and the MHCspots for the binding of SEC3 to the 14.3.d b chain
(Leder et al., 1998), in agreement with the fact that SAGs class II a1 or b1 (which corresponds to a2 in class I)
helices. However, as discussed below, the MHC b1 helixhaving other residues at these positions display different
Vb-binding specificities. Thus, SEA, SED, and SEE, is predicted to interact with the TCR Va domain. Thus,
there is only partial overlap between the binding siteswhich do not activate Vb8.2-bearing T cells, differ from
SEB at nearly all Vb-contacting positions, in particular on the TCR for SEB and for peptide/MHC (Table 2B).
By acting as a wedge between the TCR b chain and the90 and 210. Furthermore, when SEA (Schad et al., 1995)
is superposed onto SEB, the r.m.s difference in a-carbon MHC a chain, SEB circumvents the normal mechanism
for T cell activation by peptide/MHC. In addition, thepositions for 10 residues in the TCR-binding site is 2.8
AÊ . The putative TCR-binding sites of TSST-1 (Papageor- rotational orientation of TCR and MHC molecules in the
TCR-SEB-peptide/MHC complex is very different fromgiou et al., 1996) and SPEC (Roussel et al., 1997) are
markedly different from that of SEB (data not shown); that in the TCR-peptide/MHC complex (compare Fig-
ures 5A and 5C in which the TCRs are in the samethis is consistent with the finding that the Vb specificities
of TSST-1 and SPEC do not overlap with that of SEB orientation), such that the MHC class II molecule in Fig-
ure 5A must be rotated approximately 408 counterclock-(Kotzin et al., 1993; Li et al., 1997).
wise about a vertical axis to align it with the MHC class
I molecule in Figure 5C.Comparison of TCR-SEB-Peptide/MHC
and TCR-Peptide/MHC Complexes
Although no three-dimensional structure of a TCR-SAG- Role of the TCR a Chain in Stabilization of the
TCR-SAG-Peptide/MHC Complexpeptide/MHC complex has been reported, a model of
this complex may be constructed by least-squares su- A number of studies have demonstrated a functional
interaction between the TCR a chain and MHC class IIperposition of (1) the 14.3.d VbCb-SEB complex; (2) the
SEB-peptide/HLA-DR1 complex (Jardetzky et al., 1994); during T cell activation by bacterial or viral SAGs (Wood-
land and Blackman, 1993; Webb and Gascoigne, 1994;and (3) the 2C TCR ab heterodimer (Garcia et al., 1996),
which uses the same Vb element (mouse Vb8.2) as the Daly et al., 1995; Blackman and Woodland, 1996; Don-
son et al., 1997). For example, mutations at position 7714.3.d TCR (Figure 5A). The accuracy of this hypothetical
model depends on the assumption that there are no of the I-Ek b chain (Deckhut et al., 1994) and at positions
77 and 81 of HLA-DR1 b chain (Labrecque et al., 1994)major conformational changes in any of the individual
components upon complex formation; such changes were found to greatly reduce the T cell response to SEB
without affecting binding of the SAG to MHC class II,are unlikely, given that none are observed in the TCR
b-SEB or SEB-peptide/DR1 complexes. This model may suggesting contacts to the TCR. These effects may be
understood in terms of our model of the TCR-SEB-pep-be compared with the structure of the 2C TCR com-
plexed with peptide/MHC class I (Garcia et al., 1998) tide/MHC complex (Figure 5A) in which the Va domain
of the 2C TCR is predicted to interact with the MHC b1(Figures 5B and 5C). Assuming that TCRs bind MHC
class I and class II molecules in similar orientations, as helix. The putative contacts (, 4 AÊ ) are between Va
CDR2 residues Ser51, Gly52, and Asp53 and the classargued by Garboczi et al. (1996) and Garcia et al. (1998),
it is apparent that the binding of peptide/MHC to TCR II b chain residues Asp76 and Thr77 (data not shown).
The preferential expression of certain Va regionsin the TCR-peptide/MHC complex is very different from
that in the TCR-SEB-peptide/MHC complex. In the TCR- among SAG-reactive T cells has been interpreted as
evidence that these particular Vas interact with MHCpeptide/MHC complex (Figure 5B), the peptide antigen,
as well as both the a1 and a2 helices of the class I more favorably than other Vas during SAG-mediated T
cell activation (Woodland and Blackman, 1993; Webbmolecule, simultaneously engage the TCR combining
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and Gascoigne, 1994; Borrero et al., 1995; Blackman and A model of the TCR-SEB-peptide/MHC complex indi-
cates that the rotational orientation of TCR and MHCWoodland, 1996; Donson et al., 1997). The availability
of crystal structures for several ab TCR heterodimers molecules differs by about 408 from that in the TCR-
peptide/MHC complex and that there are no direct con-(Garboczi et al., 1996; Garcia et al., 1996; Housset et
al., 1997; Wang et al., 1998) allows us to examine the tacts between the TCR b chain and MHC or between
possible effects of different TCR a chains on Va-MHC bound peptide and the TCR combining site. Therefore,
interactions in the TCR-SAG-peptide/MHC complex. By even though the TCR engages peptide/MHC very differ-
superposing the Vb domain of the 14.3.d b-SEB complex ently in the two types of complexes, the end resultÐ
onto the Vb domain of TCRs A6 (Garboczi et al., 1996), highly efficient T cell activationÐis similar. This implies
N15 (Wang et al., 1998) or KB5-C20 (Housset et al., that the specific geometry of TCR engagement by pep-
1997), as descibed above for the 2C TCR, we find that tide/MHC may be less critical than other factors, such
the extent of the interaction between the Va and MHC as the affinity and kinetics of the binding reaction, in
b1 domains in the TCR-SEB-peptide/MHC complex de- triggering T cells. It is noteworthy in this regard that the
pends, in large measure, on the relative orientation of low affinities and fast off-rates characteristic of TCR-
Va and Vb domains in each TCR heterodimer. Because peptide/MHC interactions (Corr et al., 1994; Matsui et
the variability in the geometry of Va/Vb association al., 1994; Alam et al., 1996) are remarkably similar to
among these TCRs is considerable (Wilson and Garcia, those for TCR binding to SEB and other bacterial SAGs
1997; Wang et al., 1998), large differences are observed (Seth et al., 1994; Malchiodi et al., 1995; Khandekar et
in the extent of Va-MHC b1 interactions. Thus, for the al., 1997; Leder et al., 1998; Proft and Fraser, 1998).
2C TCR, Va CDR2 Ser51, Gly52, and Asp53 are predicted
to contact MHC b1 Asp76 and Thr77 in the TCR-SEB- Experimental Procedures
MHC complex; for the A6 TCR, Va CDR1 Gln30 and
Protein Expression, Purification, and CrystallizationCDR2 Tyr50, Ser51, and Asn52 contact MHC b1 Glu69,
Soluble, unglycosylated 14.3.d TCR b chain was prepared as de-Ala73, Asp76, Thr77, and His81; for the N15 TCR, Va
scribed previously (Fields et al., 1996). Wild-type SEB was cloned
CDR1 Leu29 and CDR2 Thr51 contact MHC b1 Ala73, and produced in S. aureus strain RN 4220 as described (Bohach et
Thr77, and His81; and for TCR KB-C50, no contacts al., 1990). The protein was further purified using a Pharmacia MonoS
are expected due to the particular geometry of Va/Vb cation exchange column equilibrated with 50 mM MES (pH 6.5) and
developed using a linear 0±100 mM NaCl gradient. Recombinantassociation of this TCR. In all cases where contacts
SEB V26Y was produced in BL21(DE3) Escherichia coli cells (Lederbetween Va and the MHC molecule are predicted to
et al., 1998).occur, however, these involve Va CDR2 and residues
Initial crystallization conditions were established using the broadon the MHC b1 helix pointing away from the peptide- screening method of Jancarik and Kim (1991). The concentrations
binding groove. We hypothesize that, depending on the of SEB and the TCR b chain were each approximately 10 mg/ml.
geometry of Va/Vb association and on the structure of Small prism-shaped crystals were obtained at room temperature in
9%±12% (w/v) PEG 8000, 0.1 M Tris-HCl (pH 8.5), for both the wild-the Va CDR2 loop, Va-MHC class II interactions may
type b-SEB and mutant b-SEB V26Y complexes. Larger crystals(1) contribute to stabilizing the TCR-SEB-peptide/MHC
with dimensions up to 1.0 mm 3 0.4 mm 3 0.1 mm were grown incomplex and thereby increase reactivity toward the
sitting drops by macroseeding. The crystals belong to space groupSAG; (2) have no net effect on complex stability and not
P21 with cell dimensions a 5 71.2 AÊ , b 5 83.6 AÊ , c 5 83.0 AÊ , b 5affect reactivity; or (3) destabilize the complex through 93.08 for the wild-type b-SEB complex and a 5 70.9 AÊ , b 5 83.0 AÊ ,
unfavorable contacts and thus decrease reactivity. In c 5 82.8 AÊ , b 5 92.88 for the mutant b-SEB V26Y complex. The
this way, the TCR a chain may modulate the level of unit cell volumes are compatible with the presence of two complex
molecules in the asymmetric unit with 60% solvent content.activation by SEB of T cells expressing the same Vb but
different Vas.
Data Collection and Processing
X-ray diffraction data up to 2.4 AÊ (b-SEB) and 2.6 AÊ (b-SEB V26Y)
Conclusions were collected at 1008K from one flash-cooled crystal for each com-
The structure of the complex between a TCR b chain plex using synchrotron radiation at CHESS beamline F-1 with a
(mouse Vb8.2) and SEB at 2.4 AÊ resolution shows that Princeton 2K CCD detector (Tate et al., 1995). The crystals were
soaked in 10% PEG 8000, 28% glycerol, and 0.1 M Tris-HCl (pHVb CDR2 and FR3 account for the majority of contacts
8.5) prior to flash-cooling in liquid nitrogen. Data were integrated andwith the SAG, with HV4 and FR2 playing only secondary
merged using HKL/DENZO/SCALEPACK (Otwinowski and Minor,roles. The structure enables us to explain why SEB rec-
1997), which gives 34,943 unique reflections with Rmerge 5 9.2% forognizes only certain Vb families, as well as why only b-SEB and 28,757 unique reflections with Rmerge 5 8.1% for b-SEB
certain SAGs bind mouse Vb8.2. Thus, a comparison V26Y. Further processing was performed with the CCP4 suite of
of Vb domains of known three-dimensional structure programs. The data sets are 91.5% complete to 2.4 AÊ for b-SEB
(79.1% from 2.5±2.4 AÊ ) and 97.0% complete to 2.6 AÊ for b-SEB V26Yreveals that the relative positions of CDR2 and FR3 in
(90.6% from 2.7±2.6 AÊ ). Diffraction data statistics are summarizedVbs that recognize SEB or SEC are markedly different
in Table 1.from their positions in Vbs that do not. Conversely, a
comparison of SAGs of known structure shows that the Structure Determination and Refinement
TCR-combining sites of SEA, TSST-1, and SPEC, which The structure of the wild-type b-SEB complex was solved by the
do not activate Vb8.2-bearing T cells, are clearly distin- molecular replacement method with the program AMoRe (Navaza,
1994). The search models consisted of the 14.3.d TCR b chain (Bent-guishable from those of SEB or SEC, which do. Although
ley et al., 1995; PDB accession code 1bec) and SEB (Swaminathanthere are no major rearrangements in the polypeptide
et al., 1992; PDB accession code 1SE4). Unambiguous solutionsbackbones of Vb or SEB upon complex formation, a
were found in both the cross-rotation and translation functions at
number of adjustments in side chain conformation are 4 AÊ resolution. The structure was refined by iterative cycles of simu-
evident that serve to optimize the fit between the TCR lated annealing, positional refinement, and temperature factor (B)
refinement using X-PLOR (Brunger, 1992) interspersed with modeland SAG.
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building into Fo-Fc and 2Fo-Fc electron density maps using TURBO- Brocke, S., Gaur, A., Piercy, C., Gautam, A., Gijbels, K., Fathman,
C.G., and Steinman, L. (1993). Induction of relapsing paralysis inFRODO (Roussel and Cambillau, 1989). Only procedures that re-
experimental autoimmune encephalomyelitis by bacterial superanti-duced Rfree were used in the refinement. Noncrystallographic sym-
gen. Nature 365, 642±644.metry restraints relating each individual pair of domains/molecules
were applied until the last several cycles of refinement. Water mole- Brunger, A.T. (1992). X-PLOR Version 3.1. A System for X-ray Crys-
cules were added at positions where the Fo-Fc electron density was tallography and NMR. Yale University Press, New Haven.
greater than 3s and where reasonable hydrogen bonds to protein Ciurli, C., Posnett, D.N., Sekaly, R.-P., and Denis, F. (1998). Highly
atoms or other water molecules were possible. Residues that had biased CDR3 usage in restricted sets of b chain variable regions
no electron density (TCR b1 residues 132±142, 173, 206±207, 222, during viral superantigen 9 response. J. Exp. Med. 187, 253±258.
224, 226±229, and 245, b2 residues 132±142, 220, 222, and 226±229,
Cole, B.C., and Griffiths, M.M. (1993). Triggering and exacerbationSEB1 residues 1±3, 96±109, 193±194, and 238±239, and SEB2 resi-
of autoimmune arthritis by the Mycoplasma arthritidis superantigendues 1, 56±57, 96±109, 127±129, 193±194, and 238±238, where 1
MAM. Arthritis Rheum. 36, 994±1002.and 2 refer to one of the two complex molecules in the asymmetric
Collaborative Computational Project No. 4. (1994). The CCP4 suite:unit) were retained in the model because these residues were lo-
programs for protein crystallography. Acta Crystallogr. D50, 760±763.cated in the high resolution structures of uncomplexed 14.3.d b
Conrad, B., Weidmann, E., Trucco, G., Rudert, W.A., Behboo, R.,chain and SEB (Swaminathan et al., 1992; Bentley et al., 1995).
Ricordi, C., Rodriquez-Rilo, H., Finegold, D., and Trucco, M. (1994).However, these residues were given zero atomic occupancies in
Evidence for superantigen involvement in insulin-dependent diabe-the complex. Thirty-three side chains with no electron density were
tes mellitus aetiology. Nature 371, 351±355.also retained in the model but set to zero occupancies for the same
reason. The final model contains 7,589 protein atoms and 179 water Corr, M., Slanetz, A.E., Boyd, L.F., Jelonek, M.T., Khilko, S., Al-
molecules with Rfree 5 0.309 and Rwork 5 0.228 in the range 6±2.4 AÊ . Ramadi, B.K., Kim, Y.S., Maher, S.E., Bothwell, A.L., and Margulies,
The r.m.s. deviations from ideal bond lengths and bond angles are D.H. (1994). T cell receptor-MHC class I peptide interactions: affinity,
0.006 AÊ and 1.498, respectively. A Ramachandran plot of the b-SEB kinetics, and specificity. Science 265, 946±948.
complex as analyzed using PROCHECK (Laskowski et al., 1993) Dall'Acqua, W., Goldman, E.R., Lin, W., Teng, C., Tsuchiya, D., Li,
indicates that 79.7, 19.6, and 0.7% of residues fall in favored, al- H., Ysern, X., Braden, B.C., Li, Y., Smith-Gill, S.J., et al. (1998). A
lowed, and disallowed regions, respectively. Those residues falling mutational analysis of binding interactions in an antigen-antibody
in disallowed regions in the Ramachandran plot were located in the protein-protein complex. Biochemistry 37, 7981±7991.
disulfide loop of SEB with missing electron density and were also
Daly, K., Nguyen, P., Hankley, D., Zhang, W.J., Woodland, D.L.,
in disallowed regions in the Ramachandran plot for uncomplexed
and Blackman, M.A. (1995). Contribution of the TCR a-chain to the
SEB. The structure determination of the b-SEB V26Y mutant com-
differential recognition of bacterial and retroviral superantigens. J.
plex was begun from the partially refined structure of the b-SEB
Immunol. 155, 27±34.
wild-type complex and followed similar procedures. Refinement sta-
Davies, D.R., and Padlan, E.E. (1992). Twisting into shape. Curr.tistics for both structures are summarized in Table 1.
Biol. 2, 254±256.
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